Erratum: B-RAF and its novel negative regulator reticulocalbin 1 (RCN1) modulates cardiomyocyte hypertrophy (Cardiovasc Res (2014) 102: 1 (88-96) DOI: 10.1093/cvr/cvu024);B-RAF and its novel negative regulator reticulocalbin 1 (RCN1) modulates cardiomyocyte hypertrophy

Cardiovascular Research

Volumn 102, Issue 1, 2014, Pages 88-96

  Kramann, Nadine ^a   Hasenfuß, Gerd ^a   Seidler, Tim ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

B RAF; Cardiomyocyte hypertrophy; MAPK; RCN1; Reticulocalbin 1

Indexed keywords

2 [4 (2 DIMETHYLAMINOETHOXY)PHENYL] 4 (1 HYDROXYIMINO 5 INDANYL) 5 (4 PYRIDINYL) 1H IMIDAZOLE; ADENOVIRUS VECTOR; B RAF KINASE; MITOGEN ACTIVATED PROTEIN KINASE; REGULATOR PROTEIN; RETICULOCALBIN 1; UNCLASSIFIED DRUG; BRAF PROTEIN, RAT; CALCIUM BINDING PROTEIN; PHENYLEPHRINE; RETICULOCALBIN;

ANIMAL CELL; ARTICLE; CARDIOMYOCYTE HYPERTROPHY; CELL GROWTH; CONTROLLED STUDY; DNA LIBRARY; ENZYME ACTIVITY; FETUS; GENE TRANSFER; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; LUCIFERASE ASSAY; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; ANIMAL; CARDIOMEGALY; CELL CULTURE; HUMAN; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION; WISTAR RAT;

ANIMALS; CALCIUM-BINDING PROTEINS; CARDIOMEGALY; CELLS, CULTURED; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCYTES, CARDIAC; PHENYLEPHRINE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS B-RAF; RATS, WISTAR; SIGNAL TRANSDUCTION;

EID: 84896988407     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvaa261     Document Type: Erratum

References (48)

1. Sadoshima J, Izumo S. The cellular and molecular responseofcardiac myocytestomech-anical stress. Annu Rev Physiol 1997;59:551-571.
2. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-1566.
3. Frey N, Katus HA, Olson EN, Hill JA. Hypertrophyofthe heart:anew therapeutic target? Circulation 2004;109:1580-1589.
4. Frey N, Olson EN. Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 2003;65:45-79.
5. Hill JA, Olson EN. Cardiac plasticity. N Engl J Med 2008;358:1370-1380.
6. Molkentin JD, Dorn GW 2nd. Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol 2001;63:391-426.
7. Chiloeches A, Paterson HF, Marais R, Clerk A, Marshall CJ, Sugden PH. Regulation of ras. Gtp loading and ras-raf association in neonatal rat ventricular myocytes by g protein-coupled receptor agonists and phorbol ester. Activation of the Extracellular Signal-Regulated Kinase Cascade by Phorbol Ester is Mediated by ras. J Biol Chem 1999;274: 19762-19770.
8. Ramirez MT, Sah VP, Zhao XL, Hunter JJ, Chien KR, Brown JH. The mekk-jnk pathway is stimulated by alpha1-adrenergic receptor and ras activation and is associated with in vitro and in vivo cardiac hypertrophy. J Biol Chem 1997;272:14057-14061.
9. Thorburn A, Thorburn J, Chen SY, Powers S, Shubeita HE, Feramisco JR et al. Hras-dependent pathways can activate morphological and genetic markers of cardiac muscle cell hypertrophy. J Biol Chem 1993;268:2244-2249.
10. Hunter JJ, Tanaka N, Rockman HA, Ross J Jr., Chien KR. Ventricular expression of a mlc-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice. J Biol Chem 1995;270:23173-23178.
11. Moodie SA, Wolfman A. The 3rs oflife: Ras, raf and growth regulation. Trends Genet 1994; 10:44-48.
12. Morrison DK, Cutler RE. The complexity of raf-1 regulation. Curr Opin Cell Biol 1997;9: 174-179.
13. Avruch J, Khokhlatchev A, Kyriakis JM, Luo Z, Tzivion G, Vavvas D et al. Ras activation of the raf kinase: Tyrosine kinase recruitment of the map kinase cascade. Recent Prog Horm Res 2001;56:127-155.
14. Williams NG, Roberts TM. Signal transduction pathways involving the raf proto-oncogene. Cancer Metastasis Rev 1994;13:105-116.
15. Guan KL. The mitogen activated protein kinase signal transduction pathway:from the cell surface to the nucleus. Cell Signal 1994;6:581-589.
16. Sugden PH, Clerk A. Regulation of the erk subgroup of map kinase cascades through g protein-coupled receptors. Cell Signal 1997;9:337-351.
17. Yue TL, Gu JL, Wang C, Reith AD, Lee JC, Mirabile RC et al. Extracellular signal-regulated kinase plays an essential role in hypertrophic agonists, endothelin-1 and phenylephrine-induced cardiomyocyte hypertrophy. J Biol Chem 2000;275:37895-37901.
18. Silberbach M, Gorenc T, Hershberger RE, Stork PJ, Steyger PS, Roberts CT Jr. Extracellular signal-regulated protein kinase activation is required for the anti-hypertrophic effect of atrial natriuretic factor in neonatal rat ventricular myocytes. J Biol Chem 1999; 274:24858-24864.
19. Thorburn J, Mc Mahon M, Thorburn A. Raf-1 kinase activity is necessary and sufficient for gene expression changes but not sufficient for cellular morphology changes associated with cardiac myocyte hypertrophy. J Biol Chem 1994;269:30580-30586.
20. Hines WA, Thorburn A. Ras and rho are required for galphaq-induced hypertrophic gene expression in neonatal rat cardiac myocytes. J Mol Cell Cardiol 1998;30:485-494.
21. Bueno OF, De Windt LJ, Tymitz KM, Witt SA, Kimball TR, Klevitsky R et al. The mek1-erk1/2 signaling pathway promotes compensated cardiac hypertrophy in trans-genic mice. EMBO J 2000;19:6341-6350.
22. Harris IS, Zhang S, Treskov I, Kovacs A, Weinheimer C, Muslin AJ. Raf-1 kinaseis required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload. Circulation 2004;110:718-723.
23. Mason CS, Springer CJ, Cooper RG, Superti-Furga G, Marshall CJ, Marais R. Serine and tyrosine phosphorylations cooperate in raf-1, but not b-raf activation. EMBO J 1999;18: 2137-2148.
24. Garnett MJ, Rana S, Paterson H, Barford D, Marais R. Wild-type and mutant b-raf activate c-raf through distinct mechanisms involving heterodimerization. Mol Cell 2005;20: 963-969.
25. Rushworth LK, Hindley AD, O'Neill E, Kolch W. Regulation and role of raf-1/b-raf het-erodimerization. Mol Cell Biol 2006;26:2262-2272.
26. Weber CK, Slupsky JR, Kalmes HA, Rapp UR. Active ras induces heterodimerization of craf and braf. Cancer Res 2001;61:3595-3598.
27. Marais R, Light Y, Paterson HF, Mason CS, Marshall CJ. Differential regulation of raf-1, a-raf, and b-raf by oncogenic ras and tyrosine kinases. J Biol Chem 1997;272: 4378-4383.
28. Papin C, Denouel A, Calothy G, Eychene A. Identification of signalling proteins interacting with b-raf in the yeast two-hybrid system. Oncogene 1996;12:2213-2221.
29. Jaiswal RK, Moodie SA, Wolfman A, Landreth GE. The mitogen-activated protein kinase cascade is activated by b-raf in response to nerve growth factor through interaction with p21ras. Mol Cell Biol 1994;14:6944-6953.
30. Catling AD, Reuter CW, Cox ME, Parsons SJ, Weber MJ. Partial purificationofamitogen-activated protein kinase kinase activator from bovine brain. Identification as b-raf or a b-raf-associated activity. J Biol Chem 1994;269:30014-30021.
31. Kuhn C, Frank D, Will R, Jaschinski C, Frauen R, Katus HA et al. Dyrk1a isanovel negative regulator of cardiomyocyte hypertrophy. J Biol Chem 2009;284:17320-17327.
32. Seidler T, Teucher N, Hellenkamp K, Unsold B, Grebe C, Kramps P et al. Limitations of fkbp12. 6-directed treatment strategies for maladaptive cardiac remodeling and heart failure. J Mol Cell Cardiol 2011;50:33-42.
33. Toischer K, Rokita AG, Unsold B, Zhu W, Kararigas G, Sossalla Set al. Differential cardiac remodeling in preload versus afterload. Circulation 2010;122:993-1003.
34. Klesse LJ, Meyers KA, Marshall CJ, Parada LF. Nerve growth factor induces survival and differentiation through two distinct signaling cascades in pc12 cells. Oncogene 1999;18: 2055-2068.
35. Dorn GW 2nd, Brown JH. Gq signaling in cardiac adaptation and maladaptation. Trends Cardiovasc Med 1999;9:26-34.
36. Wang L, Gout I, Proud CG. Cross-talk between the erk and p70 s6 kinase (s6k) signaling pathways. Mek-dependent Activation of s6k2 in Cardiomyocytes. J Biol Chem 2001;276: 32670-32677.
37. Rolfe M, Mc Leod LE, Pratt PF, Proud CG. Activation of protein synthesis in cardiomyo-cytesbythe hypertrophic agent phenylephrine requires the activationoferk and involves phosphorylation of tuberous sclerosis complex 2 (tsc2). Biochem J 2005;388:973-984.
38. Galabova-Kovacs G, Kolbus A, Matzen D, Meissl K, Piazzolla D, Rubiolo C et al. Erk and beyond: Insights from b-raf and raf-1 conditional knockouts. Cell Cycle 2006;5: 1514-1518.
39. Honore B, Vorum H. The crec family, a novel family of multiple ef-hand, low-affinity ca(2+)-binding proteins localised to the secretory pathway of mammalian cells. FEBS Lett 2000;466:11-18.
40. Zhang Y, Ye J, Chen D, Zhao X, Xiao X, Tai S et al. Differential expression profiling between the relative normal and dystrophic muscle tissues from the same lgmd patient. J Transl Med 2006;4:53.
41. Liu Z, Brattain MG, Appert H. Differential display of reticulocalbin in the highly invasive cell line, mda-mb-435, versus the poorly invasive cell line, mcf-7. Biochem Biophys Res Commun 1997;231:283-289.
42. Grzeskowiak R, Witt H, Drungowski M, Thermann R, Hennig S, Perrot A et al. Expression profiling of human idiopathic dilated cardiomyopathy. Cardiovasc Res 2003;59: 400-411.
43. Kent J, Lee M, Schedl A, Boyle S, Fantes J, Powell M et al. The reticulocalbin gene maps to the wagr regionin human and to the small eye harwell deletion in mouse. Genomics 1997; 42:260-267.
44. Ozawa M, Muramatsu T. Reticulocalbin, anovel endoplasmic reticulum resident ca(2+)-binding protein with multiple ef-hand motifs andacarboxyl-terminal hdel sequence. JBiol Chem 1993;268:699-705.
45. Cooper CR, Graves B, Pruitt F, Chaib H, Lynch JE, Cox AK et al. Novel surface expression of reticulocalbin 1onbone endothelial cells and human prostate cancer cells is regulated by tnf-alpha. J Cell Biochem 2008;104:2298-2309.
46. Tsukumo Y, Tsukahara S, Saito S, Tsuruo T, Tomida A. A novel endoplasmic reticulum export signal: Proline at the +2-position from the signal peptide cleavage site. J Biol Chem 2009;284:27500-27510.
47. Assadi F. C-reactive protein and incident left ventricular hypertrophy in essential hypertension. Pediatr Cardiol 2007;28:280-285.
48. Wang Q, Zhu X, Xu Q, Ding X, Chen YE, Song Q. Effect of c-reactive protein on gene expression in vascular endothelial cells. Am J Physiol Heart Circ Physiol 2005;288: H1539-H1545.